(0.11%) 5 254.00 points
(0.08%) 39 794 points
(-0.11%) 16 382 points
(2.02%) $82.99
(2.68%) $1.764
(1.32%) $2 242.00
(1.02%) $25.01
(1.39%) $922.35
(0.28%) $0.926
(0.70%) $10.84
(0.11%) $0.792
(0.13%) $92.56
Live Chart Being Loaded With Signals
Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel...
Stats | |
---|---|
Today's Volume | 988 303 |
Average Volume | 1.05M |
Market Cap | 0.00 |
EPS | $0 ( 2021-08-04 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.345 (3.58%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-07-23 | Hayes William B | Sell | 250 | Stock Option (right to buy) |
2021-07-23 | Hayes William B | Sell | 250 | Stock Option (right to buy) |
2021-07-23 | Hayes William B | Sell | 500 | Stock Option (right to buy) |
2021-07-23 | Karah Hila | Sell | 281 | Stock Option (right to buy) |
2021-07-23 | Karah Hila | Sell | 250 | Stock Option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 59 transactions |
Buy: 3 599 185 | Sell: 7 817 315 |
Volume Correlation
Intec Pharma Ltd Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Intec Pharma Ltd Correlation - Currency/Commodity
Intec Pharma Ltd Financials
Annual | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-14.30 |
Q1 | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-3.83 |
Q4 | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-3.61 |
Q3 | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-3.79 |
Financial Reports:
No articles found.
Intec Pharma Ltd
Intec Pharma Ltd, a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa, which is in a Phase III clinical trial for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients. It is also developing Accordion Pill Zaleplon that is in a Phase III clinical trial as a treatment for the induction and maintenance of sleep in patients suffering from insomnia; a product candidate, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers; and AP-CBD/THC, AP-THC, and AP-CBD product candidates with Cannabidiol and 9-Tetrahydrocannabinol for the treatment of various pain indications. Intec Pharma Ltd. has a research collaboration agreement with Merck to explore using the Accordion Pill platform for development program. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd in March 2004. Intec Pharma Ltd was founded in 2000 and is based in Jerusalem, Israel.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators